Kahaly, George J; Riedl, Michaela; König, Jochem; Pitz, Susanne; Ponto, Katharina; Diana, Tanja; Kampmann, Elena; Kolbe, Elisa; Eckstein, Anja; Moeller, Lars C; Führer, Dagmar; Salvi, Mario; Curro, Nicola; Campi, Irene; Covelli, Danila; Leo, Marenza; Marinò, Michele; Menconi, Francesca; Marcocci, Claudio; Bartalena, Luigi; Perros, Petros; Wiersinga, Wilmar M; Ayvaz, Göksun; Baldeschi, Lelio; Boborides, Kostas; Boschi, Antonella; Brix, Thomas H; Clarke, Lucy; Dayan, Colin; Daumerie, Chantal; Dickinson, A Jane; Fichter, Nicole; Hegedüs, Laszlo; Konuk, Onur; Krassas, Gerassimos E; Lane, Carol; Lazarus, John; Morris, Dan S; Mourits, Maarten.; Nardi, Marco; Neoh, Chris; Orgiazzi, Jacques; Pearce, Simon H S; von Arx, Georg; Zarkovic, Milos . (2018). Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial. The Lancet Diabetes & Endocrinology, (), S2213858718300202–.
doi:10.1016/S2213-8587(18)30020-2
